World Library  
Flag as Inappropriate
Email this Article
 

Kyowa Hakko Kirin

Kyowa Hakko Kirin Co., Ltd.
Type Public KK
Traded as TYO: 4151
FWB: KY4
Nikkei 225 Component
Industry
Founded July 1, 1949
Headquarters Ohtemachi Building, 1-6-1, Ōtemachi, Chiyoda-ku, Tokyo 100-8185, Japan
Key people Nobuo Hanai, (CEO and President)
Products
Revenue

$ 3.548 billion USD (FY 2013)

Increase (¥ 340.61 billion JPY) (FY 2013)
Net income

$ 31.32 million USD (FY 2013)

Increase (¥ 30.07 billion JPY) (FY 2013)
Employees 7,152 (consolidated) (as of December 31, 2013)
Parent Kirin Holdings Company, Limited
Subsidiaries 47 (33 in Japan and 14 overseas countries)
Website Official website
Footnotes / references
[1][2][3]

Kyowa Hakko Kirin Co., Ltd. (協和発酵キリン株式会社 Kyōwa Hakkō Kirin Kabushiki Kaisha) is a Japanese pharmaceutical and biotechnology company under the Kirin Holdings, and is among the 40 largest in the world by revenue. The company is headquartered in Chiyoda-ku, Tokyo and is a member of the Nikkei 225 stock index.[4] [5]

Contents

  • History 1
  • Business segments and products 2
  • References 3
  • External links 4

History

On July 1, 1949 the forerunner of the present company, Kyowa Hakko Kogyo Co., Ltd. is established. Following the merger with Kirin Pharma Co., Ltd., on October 1, 2008 the company changed its name to its present.

On July 11, 2014, the KHK subsidiary, ProStrakan Group, acquired Archimedes Pharma from the Novo Nordisk Foundation for $394 million [6]

Business segments and products

References

  1. ^ "Kyowa Hakko Kirin Company Overview". Retrieved March 14, 2014. 
  2. ^ "Kyowa Hakko Kirin Corporate Profile". Retrieved March 14, 2014. 
  3. ^ "Kyowa Hakko Kirin Annual Report 2012". Retrieved March 14, 2014. 
  4. ^ 日経平均プロフィル [Nikkei 225 profile] (in Japanese). Nikkei. Retrieved May 27, 2010. 
  5. ^ "Top 50 Pharma Companies by 2012 Revenue". Wildwood Ventures Ltd. Retrieved March 14, 2014. 
  6. ^ http://www.genengnews.com/gen-news-highlights/khk-s-prostrakan-acquires-archimedes-pharma-for-394m/81250094/
  7. ^ "FY 2013 Consolidated Financial Summary". Retrieved March 14, 2014. 

External links

  • Official website
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 


Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.